These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18022357)

  • 1. Gaucher disease: forging a new path to the lysosome.
    Griffiths GM
    Cell; 2007 Nov; 131(4):647-9. PubMed ID: 18022357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.
    Reczek D; Schwake M; Schröder J; Hughes H; Blanz J; Jin X; Brondyk W; Van Patten S; Edmunds T; Saftig P
    Cell; 2007 Nov; 131(4):770-83. PubMed ID: 18022370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal integral membrane protein-2: a new player in lysosome-related pathology.
    Gonzalez A; Valeiras M; Sidransky E; Tayebi N
    Mol Genet Metab; 2014 Feb; 111(2):84-91. PubMed ID: 24389070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosome sorting of β-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor.
    Zhao Y; Ren J; Padilla-Parra S; Fry EE; Stuart DI
    Nat Commun; 2014 Jul; 5():4321. PubMed ID: 25027712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LIMP-2/SCARB2 binding motif on acid β-glucosidase: basic and applied implications for Gaucher disease and associated neurodegenerative diseases.
    Liou B; Haffey WD; Greis KD; Grabowski GA
    J Biol Chem; 2014 Oct; 289(43):30063-74. PubMed ID: 25202012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannose 6-phosphate-independent Lysosomal Sorting of LIMP-2.
    Blanz J; Zunke F; Markmann S; Damme M; Braulke T; Saftig P; Schwake M
    Traffic; 2015 Oct; 16(10):1127-36. PubMed ID: 26219725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease.
    Jian J; Tian QY; Hettinghouse A; Zhao S; Liu H; Wei J; Grunig G; Zhang W; Setchell KDR; Sun Y; Overkleeft HS; Chan GL; Liu CJ
    EBioMedicine; 2016 Nov; 13():212-224. PubMed ID: 27789271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, β-glucocerebrosidase.
    Jović M; Kean MJ; Szentpetery Z; Polevoy G; Gingras AC; Brill JA; Balla T
    Mol Biol Cell; 2012 Apr; 23(8):1533-45. PubMed ID: 22337770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GCase and LIMP2 Abnormalities in the Liver of Niemann Pick Type C Mice.
    van der Lienden MJC; Aten J; Marques ARA; Waas ISE; Larsen PWB; Claessen N; van der Wel NN; Ottenhoff R; van Eijk M; Aerts JMFG
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered lysosome distribution is an early neuropathological event in neurological forms of Gaucher disease.
    Zigdon H; Meshcheriakova A; Farfel-Becker T; Volpert G; Sabanay H; Futerman AH
    FEBS Lett; 2017 Mar; 591(5):774-783. PubMed ID: 28186340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance.
    Rothaug M; Zunke F; Mazzulli JR; Schweizer M; Altmeppen H; Lüllmann-Rauch R; Kallemeijn WW; Gaspar P; Aerts JM; Glatzel M; Saftig P; Krainc D; Schwake M; Blanz J
    Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15573-8. PubMed ID: 25316793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of active endogenous and exogenous β-glucocerebrosidase by correlative light-electron microscopy in human fibroblasts.
    van Meel E; Bos E; van der Lienden MJC; Overkleeft HS; van Kasteren SI; Koster AJ; Aerts JMFG
    Traffic; 2019 May; 20(5):346-356. PubMed ID: 30895685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudophosphatase STYXL1 depletion enhances glucocerebrosidase trafficking to lysosomes via ER stress.
    Patel S; Bhatt AM; Bhansali P; Setty SRG
    Traffic; 2023 Jul; 24(7):254-269. PubMed ID: 37198709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells.
    Siebert M; Westbroek W; Chen YC; Moaven N; Li Y; Velayati A; Saraiva-Pereira ML; Martin SE; Sidransky E
    RNA Biol; 2014; 11(10):1291-300. PubMed ID: 25584808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of β-GC trafficking improves the lysosome function in Gaucher disease.
    Patel S; Radhakrishnan D; Kumari D; Bhansali P; Setty SRG
    Traffic; 2023 Oct; 24(10):489-503. PubMed ID: 37491971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical histidine residue within LIMP-2 mediates pH sensitive binding to its ligand β-glucocerebrosidase.
    Zachos C; Blanz J; Saftig P; Schwake M
    Traffic; 2012 Aug; 13(8):1113-23. PubMed ID: 22537104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shortcut to the lysosome: the mannose-6-phosphate-independent pathway.
    Coutinho MF; Prata MJ; Alves S
    Mol Genet Metab; 2012 Nov; 107(3):257-66. PubMed ID: 22884962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase.
    Blanz J; Groth J; Zachos C; Wehling C; Saftig P; Schwake M
    Hum Mol Genet; 2010 Feb; 19(4):563-72. PubMed ID: 19933215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation).
    Zimmer KP; le Coutre P; Aerts HM; Harzer K; Fukuda M; O'Brien JS; Naim HY
    J Pathol; 1999 Aug; 188(4):407-14. PubMed ID: 10440752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.
    Wong YC; Krainc D
    Mov Disord; 2016 Nov; 31(11):1610-1618. PubMed ID: 27619775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.